Boehringer Ingelheim and Weill Cornell Partner to Investigate Ways of Halting COPD Progression
Lung Disease News
“The new collaboration is an excellent example of our unique partnering approach and our focus on early innovation, underscoring our ambition to develop the next generation of medical treatments for patients with COPD,” said Clive R. Wood, senior ...
Medicare Part D coverage and cost-sharing for inhalers for COPD
Pharmacy Today, American Pharmacists Association, pharmacist.com
In a recent study, researchers examined coverage and cost-sharing for chronic obstructive pulmonary disease (COPD) inhalers in Medicare Part D plans. The authors assessed the June 2015 Centers for Medicare and Medicaid Services Prescription Drug ...
COPD News Today
Blocking COPD Risk-factor Molecule Could Be Path to Treatment, Study Reports
COPD News Today
Blocking a molecule that is a risk factor for chronic obstructive pulmonary disease (COPD) could be a path toward treating the disease, according to a study. Researchers demonstrated that blocking a factor known as RAGE (receptor for advanced glycan ...
Chronic rhinosinusitis is associated with higher prevalence and severity of bronchiectasis in patients with COPD
Dove Medical Press
Background and purpose: Bronchiectasis revealed by high-resolution computed tomography (HRCT) is common in chronic obstructive pulmonary disease (COPD), but the causes and risk factors remain to be determined. Chronic rhinosinusitis (CRS) is ...
COPD is preventable and treatable - Hyderabad - The Hindu